Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 146

1.

Human Cardiac Organoids for Disease Modeling.

Nugraha B, Buono MF, von Boehmer L, Hoerstrup SP, Emmert MY.

Clin Pharmacol Ther. 2018 Nov 11. doi: 10.1002/cpt.1286. [Epub ahead of print] Review.

PMID:
30415499
2.

Cellular self-assembly into 3D microtissues enhances the angiogenic activity and functional neovascularization capacity of human cardiopoietic stem cells.

Wolint P, Bopp A, Woloszyk A, Tian Y, Evrova O, Hilbe M, Giovanoli P, Calcagni M, Hoerstrup SP, Buschmann J, Emmert MY.

Angiogenesis. 2018 Jul 16. doi: 10.1007/s10456-018-9635-4. [Epub ahead of print]

PMID:
30014173
3.

Computational modeling guides tissue-engineered heart valve design for long-term in vivo performance in a translational sheep model.

Emmert MY, Schmitt BA, Loerakker S, Sanders B, Spriestersbach H, Fioretta ES, Bruder L, Brakmann K, Motta SE, Lintas V, Dijkman PE, Frese L, Berger F, Baaijens FPT, Hoerstrup SP.

Sci Transl Med. 2018 May 9;10(440). pii: eaan4587. doi: 10.1126/scitranslmed.aan4587.

PMID:
29743347
4.

Development of an Off-the-Shelf Tissue-Engineered Sinus Valve for Transcatheter Pulmonary Valve Replacement: a Proof-of-Concept Study.

Motta SE, Fioretta ES, Dijkman PE, Lintas V, Behr L, Hoerstrup SP, Emmert MY.

J Cardiovasc Transl Res. 2018 Jun;11(3):182-191. doi: 10.1007/s12265-018-9800-6. Epub 2018 Mar 20.

PMID:
29560553
5.

Production-scale fibronectin nanofibers promote wound closure and tissue repair in a dermal mouse model.

Chantre CO, Campbell PH, Golecki HM, Buganza AT, Capulli AK, Deravi LF, Dauth S, Sheehy SP, Paten JA, Gledhill K, Doucet YS, Abaci HE, Ahn S, Pope BD, Ruberti JW, Hoerstrup SP, Christiano AM, Parker KK.

Biomaterials. 2018 Jun;166:96-108. doi: 10.1016/j.biomaterials.2018.03.006. Epub 2018 Mar 5.

PMID:
29549768
6.

Puncturing of lyophilized tissue engineered vascular matrices enhances the efficiency of their recellularization.

Książek AA, Frese L, Dijkman PE, Sanders B, Motta SE, Weber B, Hoerstrup SP.

Acta Biomater. 2018 Apr 15;71:474-485. doi: 10.1016/j.actbio.2018.02.029. Epub 2018 Mar 2.

PMID:
29505888
7.

Translational cardiac stem cell therapy: advancing from first-generation to next-generation cell types.

Cambria E, Pasqualini FS, Wolint P, Günter J, Steiger J, Bopp A, Hoerstrup SP, Emmert MY.

NPJ Regen Med. 2017 Jun 13;2:17. doi: 10.1038/s41536-017-0024-1. eCollection 2017. Review.

8.

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions.

Slamecka J, Laurini J, Shirley T, Hoerstrup SP, Weber B, Owen L, McClellan S.

J Vis Exp. 2017 Nov 27;(129). doi: 10.3791/56003.

PMID:
29286443
9.

Off-the-shelf tissue engineered heart valves for in situ regeneration: current state, challenges and future directions.

Motta SE, Lintas V, Fioretta ES, Hoerstrup SP, Emmert MY.

Expert Rev Med Devices. 2018 Jan;15(1):35-45. doi: 10.1080/17434440.2018.1419865. Epub 2017 Dec 28. Review.

PMID:
29257706
10.

A Simple Modification Method to Obtain Anisotropic and Porous 3D Microfibrillar Scaffolds for Surgical and Biomedical Applications.

Hosseini V, Evrova O, Hoerstrup SP, Vogel V.

Small. 2018 Jan;14(4). doi: 10.1002/smll.201702650. Epub 2017 Dec 4.

PMID:
29205905
11.

Induced pluripotent stem cells derived from human amnion in chemically defined conditions.

Slamecka J, McClellan S, Wilk A, Laurini J, Manci E, Hoerstrup SP, Weber B, Owen L.

Cell Cycle. 2018;17(3):330-347. doi: 10.1080/15384101.2017.1403690. Epub 2018 Feb 7.

PMID:
29143560
12.

Challenges in translating tissue engineered heart valves into clinical practice.

Emmert MY, Hoerstrup SP.

Eur Heart J. 2017 Mar 1;38(9):619-621. doi: 10.1093/eurheartj/ehx075. No abstract available.

PMID:
29121258
13.

Next generation heart valve substitutes.

Emmert MY, Hoerstrup SP.

Eur Heart J. 2017 Mar 1;38(9):617-618. doi: 10.1093/eurheartj/ehx074. No abstract available.

PMID:
29121257
14.

Monitoring and manipulating cellular crosstalk during kidney fibrosis inside a 3D in vitro co-culture.

Nugraha B, Mohr MA, Ponti A, Emmert MY, Weibel F, Hoerstrup SP, Moll S, Certa U, Prunotto M, Pantazis P.

Sci Rep. 2017 Nov 3;7(1):14490. doi: 10.1038/s41598-017-12683-y.

15.

Regenerative transcatheter valves.

Emmert MY, Hoerstrup SP.

Eur Heart J. 2017 Sep 21;38(36):2710-2713. doi: 10.1093/eurheartj/ehx476. No abstract available.

PMID:
29044390
16.

Biofabricating atherosclerotic plaques: In vitro engineering of a three-dimensional human fibroatheroma model.

Mallone A, Stenger C, Von Eckardstein A, Hoerstrup SP, Weber B.

Biomaterials. 2018 Jan;150:49-59. doi: 10.1016/j.biomaterials.2017.09.034. Epub 2017 Sep 28.

17.

Intrinsic remote conditioning of the myocardium as a comprehensive cardiac response to ischemia and reperfusion.

Pavo N, Lukovic D, Zlabinger K, Lorant D, Goliasch G, Winkler J, Pils D, Auer K, Ankersmit HJ, Giricz Z, Sárközy M, Jakab A, Garamvölgyi R, Emmert MY, Hoerstrup SP, Hausenloy DJ, Ferdinandy P, Maurer G, Gyöngyösi M.

Oncotarget. 2017 Jun 12;8(40):67227-67240. doi: 10.18632/oncotarget.18438. eCollection 2017 Sep 15.

18.

Clot-entrapped blood cells in synergy with human mesenchymal stem cells create a pro-angiogenic healing response.

Burkhardt MA, Gerber I, Moshfegh C, Lucas MS, Waser J, Emmert MY, Hoerstrup SP, Schlottig F, Vogel V.

Biomater Sci. 2017 Sep 26;5(10):2009-2023. doi: 10.1039/c7bm00276a.

PMID:
28809406
19.

Amniotic Fluid Cells Show Higher Pluripotency-Related Gene Expression Than Allantoic Fluid Cells.

Kehl D, Generali M, Görtz S, Geering D, Slamecka J, Hoerstrup SP, Bleul U, Weber B.

Stem Cells Dev. 2017 Oct 1;26(19):1424-1437. doi: 10.1089/scd.2016.0352. Epub 2017 Aug 14.

PMID:
28708036
20.

Comparative analysis of poly-glycolic acid-based hybrid polymer starter matrices for in vitro tissue engineering.

Generali M, Kehl D, Capulli AK, Parker KK, Hoerstrup SP, Weber B.

Colloids Surf B Biointerfaces. 2017 Oct 1;158:203-212. doi: 10.1016/j.colsurfb.2017.06.046. Epub 2017 Jul 1.

PMID:
28697435

Supplemental Content

Loading ...
Support Center